Carboxylic acid-functionalized SBA-15 nanorods for gemcitabine delivery

Journal of Nanoparticle Research

Volumn 17, Issue 3, 2015, Pages

  Bahrami, Zohreh ^a,b   Badiei, Alireza ^a   Ziarani, Ghodsi Mohammadi ^c  

^a UNIVERSITY OF TEHRAN   (Iran)

^b SEMNAN UNIVERSITY   (Iran)

^c ALZAHRA UNIVERSITY   (Iran)

Author keywords

Carboxylic acid; Gemcitabine; Nanorods; SBA 15; Surface functionalization

Indexed keywords

ADSORPTION; CARBOXYLIC ACIDS; CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; NANORODS; SILICA; SILICA NANOPARTICLES; THALLIUM ALLOYS; THALLIUM METALLOGRAPHY; THERMOGRAVIMETRIC ANALYSIS; ULTRAVIOLET SPECTROSCOPY; URANIUM METALLOGRAPHY; VANADIUM METALLOGRAPHY;

3-AMINOPROPYL TRIMETHOXYSILANE; ADSORPTION CAPACITIES; CARBOXYLIC ACID DERIVATIVES; FUNCTIONALIZED SBA-15; GEMCITABINE; MESOPOROUS SILICA NANOPARTICLES; SBA-15; SURFACE FUNCTIONALIZATION;

TARGETED DRUG DELIVERY;

3 AMINOPROPYLTRIETHOXYSILANE; 3 [2 (2 AMINOETHYLAMINO)PROPYL TRIMETHOXYSILANE; CARBOXYLIC ACID DERIVATIVE; GEMCITABINE; N (2 AMINOETHYL) 3 AMINOPROPYLTRIMETHOXYSILANE; NANOROD; NITROGEN; SBA 15 NANOROD; SILANE DERIVATIVE; SILICA NANOPARTICLE; SUCCINIC ANHYDRIDE; UNCLASSIFIED DRUG;

ADSORPTION; ARTICLE; DESORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; SYNTHESIS; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; X RAY CRYSTALLOGRAPHY;

EID: 84924678477     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-015-2929-1     Document Type: Article

References (44)

1. Andersson J, Rosenholm J, Areva S, Lindén M (2004) Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices. Chem Mater 16(21):4160–4167
2. Badiei A, Goldooz H, Ziarani GM (2011) A novel method for preparation of 8-hydroxyquinoline functionalized mesoporous silica: aluminum complexes and photoluminescence studies. Appl Surf Sci 257(11):4912–4918
3. Bahrami Z, Badiei A, Atyabi F (2014) Surface functionalization of SBA-15 nanorods for anticancer drug delivery. Chem Eng Res Des 92:1296–1303
4. Barbé C, Bartlett J, Kong L, Finnie K, Lin HQ, Larkin M, Calleja S, Bush A, Calleja G (2004) Silica particles: a novel drug-delivery system. Adv Mater 16:1949–1966
5. Braakhuis BJ, Dongen GAV, Vermorken JB, Snow GB (1991) Preclinical in vivo activity of 2′,2′-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer. Cancer Res 51:211–214
6. Burris H, Storniolo AM (1997) Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil. Eur J Cancer 33:S18–S22
7. Cariono IS, Pasqua L, Testa F, Aiello R, Puoci F, Iemma F, Picci N (2007) Silica-based mesoporous materials as drug delivery system for methotrexate release. Drug Deliv 14:491–495
8. Cauda V, Schlossbauer A, Bein T (2010) Bio-degradation study of colloidal mesoporous silica nanoparticles: effect of surface functionalization with organo-silanes and poly (ethylene glycol). Microporous Mesoporous Mater 132(1–2):60–71
9. Fan J, Lei J, Wang L, Yu C, Tu B, Zhao D (2003) Rapid and high-capacity immobilization of enzymes based on mesoporous silicas with controlled morphologies. Chem Commun 17:2140–2141
10. Halamová D, Badaničová M, Zeleňák V, Gondová T, Vainio U (2010) Naproxen drug delivery using periodic mesoporous silica SBA-15. Appl Surf Sci 256(22):6489–6494
11. Horcajada P, Rámila A, Pérez-Pariente J, Vallet Regı M (2004) Influence of pore size of MCM-41 matrices on drug delivery rate. Microporous Mesoporous Mater 68(1–3):105–109
12. Horcajada P, Rámila A, Férey G, Vallet-Regí M (2006) Influence of superficial organic modification of MCM-41 matrices on drug delivery rate. Solid State Sci 8(10):1243–1249
13. Izquierdo-Barba I, Sanchez-Salcedo S, Colilla M, Feito MJ, Ramirez-Santillan C, Portoles MT, Vallet-Regi M (2011) Inhibition of bacterial adhesion on biocompatible zwitterionic SBA-15 mesoporous materials. Acta Biomater 7(7):2977–2985
14. Jaroniec CP, Kruk M, Jaroniec M, Sayari A (1998) Tailoring surface and structural properties of MCM-41 silicas by bonding organosilanes. J Phys Chem B 102(28):5503–5510
15. Khaniani Y, Badiei A, Mohammadi Ziarani G (2012) Application of clickable nanoporous silica surface for immobilization of ionic liquids. J Mater Res 27(6):932–938
16. Lee HI, Kim JH, Stucky GD, Shi Y, Pak C, Kim JM (2010) Morphology-selective synthesis of mesoporous SBA-15 particles over micrometer, submicrometer and nanometer scales. J Mater Chem 20(39):8483–8487
17. Lei J, Fan J, Yu C, Zhang L, Jiang S, Tu B, Zhao D (2004) Immobilization of enzymes in mesoporous materials: controlling the entrance to nanospace. Microporous Mesoporous Mater 73(3):121–128
18. Lu J, Liong M, Zink JI, Fuyuhiko T (2007) Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 3(8):1341–1346
19. Moritz M, Łaniecki M (2012) SBA-15 mesoporous material modified with APTES as the carrier for 2-(3-benzoylphenyl)propionic acid. Appl Surf Sci 258(19):7523–7529
20. Munoz B, Ramila A, Perez-Pariente J, Dıaz I, Vallet-Regı M (2003) MCM-41 organic modification as drug delivery rate regulator. Chem Mater 15:500–503
21. Ng JBS, Kamali-Zare P, Brismar H, Bergström L (2008) Release and molecular transport of cationic and anionic fluorescent molecules in mesoporous silica spheres. Langmuir 24(19):11096–11102
22. Nieto A, Balas F, Colilla M, Manzano M, Vallet-Regí M (2008) Functionalization degree of SBA-15 as key factor to modulate sodium alendronate dosage. Microporous Mesoporous Mater 116(1–3):4–13
23. Nunes CD, Vaz PD, Fernandes AC, Ferreira P, Romäo CC, Calhordo MJ (2007) Loading and delivery of sertraline using inorganic micro and mesoporous materials. Eur J Pharm Biopharm 66:357–365
24. Patra CR, Bhattacharya R, Mukhopadhyay D, Mukherjee P (2010) Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev 62:346–361
25. Popova MD, Szegedi A, Kolev IN, Mihaly J, Tzankov BS, Momekov GT, Lambov NG, Yoncheva KP (2012) Carboxylic modified spherical mesoporous silicas small a, Cyrillics drug delivery carriers. Int J Pharm 436(1–2):778–785
26. Prokopowicz M, Przyjazny A (2007) Synthesis of sol-gel mesoporous silica materials providing a slow release of doxorubicin. J Microencapsul 24:694–713
27. Qu F, Zhu G, Huang S, Li S, Sun J, Zhang D, Qiu S (2006) Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica. Microporous Mesoporous Mater 92(1–3):1–9
28. Sevimli F, Yılmaz A (2012) Surface functionalization of SBA-15 particles for amoxicillin delivery. Microporous Mesoporous Mater 158:281–291
29. Shen SC, Ng WK, Chia L, Hu J, Tan RB (2011) Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size. Int J Pharm 410(1–2):188–195
30. Socrates G (2004) Infrared and Raman Characteristic group frequencies: tables and charts. Wiley, Chichester
31. Song SW, Hidajat K, Kawi S (2005) Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix−drug interactions. Langmuir 21(21):9568–9575
32. Strømme M, Brohede U, Atluri R, Garcia-Bennett AE (2009) Mesoporous silica-based nanomaterials for drug delivery: evaluation of structural properties associated with release rate. Nanomed Nanobiotech 1(1):140–148
33. Szegedi A, Popova M, Goshev I, Mihály J (2011) Effect of amine functionalization of spherical MCM-41 and SBA-15 on controlled drug release. J Solid State Chem 184:1201–1207
34. Tang Q, Xu Y, Wu D, Sun Y (2006) A study of carboxylic-modified mesoporous silica in controlled delivery for drug famotidine. J Solid State Chem 179(5):1513–1520
35. Tourné-Péteilh C, Lerner DA, Charnay C, Nicole L, Begu S, Devoisselle JM (2003) The potential of ordered mesoporous silica for the storage of drugs: the example of a pentapeptide encapsulated in aMSU-Tween 80. Chem Phys Chem 4:281–286
36. Tozuka Y, Sugiyama E, Takeuchi H (2010) Release profile of insulin entrapped on mesoporous materials by freeze-thaw method. Int J Pharm 386:172–177
37. Tsai CP, Hung Y, Chou YH, Huang DM, Hsiao JK, Chang C, Chen YC, Mou CY (2008) High-contrast paramagnetic fluorescent mesoporous silica nanorods as a multifunctional cell-imaging probe. Small 4(2):186–191
38. Vallet-Regí M, Ruiz-González L, Izquierdo-Barba I, Gonzalez-Callbet JM (2006) Revisiting silica based ordered mesoporous materials: medical application. J Mater Chem 16:26–31
39. 3+ions chemosensor by covalent coupling fluorene onto the mono, di- and tri-ammonium functionalized nanoporous silica type SBA-15. Appl Surf Sci 279:121–128
40. Yang LM, Wang YJ, Luo GS, Dai YY (2005a) Functionalization of SBA-15 mesoporous silica with thiol or sulfonic acid groups under the crystallization conditions. Microporous Mesoporous Mater 84(1–3):275–282
41. Yang Q, Wang S, Fan P, Wang L, Di Y, Lin K, Xiao FS (2005b) pH-responsive carrier system based on carboxylic acid modified mesoporous silica and polyelectrolyte for drug delivery. Chem Mater 17(24):5999–6003
42. Yuan L, Tang Q, Yang D, Zhang JZ, Zhang F, Hu J (2011) Preparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug delivery. J Phys Chem C 115(20):9926–9932
43. Zeng W, Qian XF, Zhang YB, Yin J, Zhu ZK (2005) Organic modified mesoporous MCM-41 through solvothermal process as drug delivery system. Mater Res Bull 40(5):766–772
44. Zhuravlev LT (2000) The surface chemistry of amorphous silica. Zhuravlev model. Colloids Surf A 173(1–3):1–38